Long non-coding RNA PSMA3-AS1 promotes glioma progression through modulating the miR-411-3p/HOXA10 pathway
Authors:
Open Access
- 22 July 2021
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 21 (1) , 1-10
Abstract
Background: Glioma is a common type of brain tumor and is classified as low and high grades according to morphology and molecules. Growing evidence has proved that long non-coding RNAs (lncRNAs) play pivotal roles in numerous tumors or diseases including glioma. Proteasome 20S subunit alpha 3 antisense RNA 1 (PSMA3-AS1), as a member of lncRNAs, has been disclosed to play a tumor-promoting role in cancer progression. However, the role of PSMA3-AS1 in glioma remains unknown. Therefore, we concentrated on researching the regulatory mechanism of PSMA3-AS1 in glioma. Methods: PSMA3-AS1 expression was detected using RT-qPCR. Functional assays were performed to measure the effects of PSMA3-AS1 on glioma progression. After that, ENCORI (http://starbase.sysu.edu.cn/) database was used to predict potential genes that could bind to PSMA3-AS1, and miR-411-3p was chosen for further studies. The interaction among PSMA3-AS1, miR-411-3p and homeobox A10 (HOXA10) were confirmed through mechanism assays. Results: PSMA3-AS1 was verified to be up-regulated in glioma cells and promote glioma progression. Furthermore, PSMA3-AS1 could act as a competitive endogenous RNA (ceRNA) for miR-411-3p to regulate HOXA10 and thus affecting glioma progression. Conclusion: PSMA3-AS1 stimulated glioma progression via the miR-411-3p/HOXA10 pathway, which might offer a novel insight for the therapy and treatment of glioma.Keywords
Funding Information
- the Special Funding for Guangxi Special Experts (No: GRCT [2019]13)
- Guangxi Medical High-level Leading Talents Training “139” Project (No: GWKJ [2018] 22)
- Guangxi Natural Science Foundation (No:2017GXNSFAA198059)
This publication has 25 references indexed in Scilit:
- Glioma Subclassifications and Their Clinical SignificanceNeurotherapeutics, 2017
- Gliomas: New Perspectives in Diagnosis, Treatment and PrognosisCurrent Topics in Medicinal Chemistry, 2017
- Long noncoding RNA (lincRNA), a new paradigm in gene expression controlFunctional & Integrative Genomics, 2016
- Mechanisms of long noncoding RNA function in development and diseaseCellular and Molecular Life Sciences, 2016
- Analyzing MiRNA–LncRNA Interactions2016
- Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10+/CD44+ is potential prognostic biomarker for gastric cancerEuropean Journal of Cell Biology, 2015
- HOXA10 controls proliferation, migration and invasion in oral squamous cell carcinoma2015
- The Evolving Role of Molecular Markers in the Diagnosis and Management of Diffuse GliomaClinical Cancer Research, 2014
- Functional Nanoparticles in Targeting Glioma Diagnosis and TherapiesJournal of Nanoscience and Nanotechnology, 2014
- HOXA10 Regulates p53 Expression and Matrigel Invasion in Human Breast Cancer CellsCancer Biology & Therapy, 2004